STACEY BERG to Protein-Tyrosine Kinases
This is a "connection" page, showing publications STACEY BERG has written about Protein-Tyrosine Kinases.
Connection Strength
0.169
-
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312). Clin Cancer Res. 2020 03 15; 26(6):1213-1219.
Score: 0.157
-
Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates. Cancer Chemother Pharmacol. 2004 Jan; 53(1):39-42.
Score: 0.013